Petar Svorcan

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 20, 2026

Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

Journal: Pharmaceutics

Published: May 29, 2026

Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.

Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.

Journal: Clinical and experimental gastroenterology

Published: February 18, 2026

Genetic risk of alcohol-related liver cirrhosis: Associations of PNPLA3, TM6SF2, and a two-variant polygenic risk score.

Genetic risk of alcohol-related liver cirrhosis: Associations of PNPLA3, TM6SF2, and a two-variant polygenic risk score.

Journal: Biomolecules & biomedicine

Published: September 18, 2025

Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.

Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.

Journal: PloS one

Published: August 01, 2025

Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Journal: Biomedicines

Published: July 01, 2025

Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 16, 2025

Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study.

Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study.

Journal: International journal of molecular sciences

Published: March 05, 2025

Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease.

Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: January 02, 2025

Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability.

Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability.

Journal: Biomedicines

Published: November 29, 2024

Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics.

Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics.

Journal: Pharmaceutics

Published: November 28, 2024

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.

Journal: Antibiotics (Basel, Switzerland)

Published: June 04, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026